Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07217574 · ClinicalTrials.gov registry record

Program in Oncology for Tribal Health Systems.

A clinical trial of Patient Outcomes, sponsored by University of Oklahoma.

Recruiting
Registry status
187
Enrollment target
1
Study location

NCT07217574: Recruiting study of Patient Outcomes, sponsored by University of Oklahoma.

NCT07217574 is a study of Patient Outcomes that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 187 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07217574, a study of Patient Outcomes, is actively recruiting participants, sponsored by University of Oklahoma.

RECRUITING
Registry status
187 participants
Enrollment target
1
Study location

Study Summary

This clinical trial aims to develop and implement more navigation assistance programs tailored specifically for Native American cancer patients, addressing the current lack of available support. The goal is to improve communication barriers within the healthcare system by fostering a collaborative approach between the Stephenson Cancer Center (SCC) and tribally operated healthcare systems (ITU). Through this partnership, the trial seeks to enhance patient outcomes by providing culturally sensitive, coordinated care.

Primary Outcome

All participants will complete the Patient Satisfaction with Cancer Care (PSCC) at baseline and monthly during the study duration.

Conditions Studied

Interventions

  • OTHER C3PO

Study Locations (1)

Oklahoma

  • OU Health Stephenson Cancer Center - Oklahoma City

Trial Details

FieldValue
Enrollment Target 187 participants
Start Date 2026-03
Est. Completion 2031-03
University of Oklahoma

358 total trials

What NCT07217574 shows while recruiting

NCT07217574 is an observational study that tracks outcomes without assigning an intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Patient Outcomes appearing as the primary indexed condition, and to 1 intervention - of which C3PO is the first listed.

NCT07217574 reports a single indexed study location in Oklahoma.

Frequently Asked Questions

What is clinical trial NCT07217574 about?

NCT07217574 is a clinical study titled "Program in Oncology for Tribal Health Systems.". This clinical trial aims to develop and implement more navigation assistance programs tailored specifically for Native American cancer patients, addressing the current lack of available support. The goal is to improve communication barriers within the healthcare system by fostering a collaborative a...

What is the current status of trial NCT07217574?

This trial is currently recruiting. The enrollment target is 187 participants. The study started on 2026-03. Estimated completion is 2031-03.

What conditions does trial NCT07217574 study?

This clinical trial studies the following conditions: Patient Outcomes.

What interventions are being tested in trial NCT07217574?

The interventions under investigation include: C3PO (OTHER).

Who is sponsoring clinical trial NCT07217574?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07217574 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patient Outcomes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06153251 · 187 participants · Phase 1

    A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

  • NCT06254898 · 187 participants · NA

    Use of Incentives for Stressful Medical Procedures

  • NCT07062237 · 187 participants · NA

    A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence

  • NCT07306559 · 187 participants · Phase 1

    A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07217574, the US trial registry maintained by the National Library of Medicine. NCT07217574 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.